$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
阿扎胞苷片在美国获批维持治疗急性髓性白血病(AML)
2025-10-19 11:44:20
Check Details
缓解期AML患者首个一线口服维持疗法-阿扎胞苷片
2025-10-19 11:44:20
Check Details
治疗急性髓性白血病吉妥单抗新药介绍!
2025-10-19 11:44:20
Check Details
阿卡替尼VS伊布替尼:阿卡替尼治疗CLL的毒副作用更小,安全性更高
2025-10-19 11:44:20
Check Details
Magrolimab治疗急性髓细胞白血病的临床招募已经启动
2025-10-19 11:44:20
Check Details
抗癌药杜韦利西布可用于治疗三种淋巴瘤
2025-10-19 11:44:20
Check Details
尼洛替尼注意事项有哪些?尼洛替尼疗效怎么样?
2025-10-19 11:44:20
Check Details
美国PH+慢性粒细胞白血病的一线用药—博舒替尼
2025-10-19 11:44:20
Check Details
博舒替尼(Bosutinib)在国内上市了吗?多少钱一盒
2025-10-19 11:44:20
Check Details
“即用型”NK细胞疗法:FDA授予CYNK-001 快速通道指定,用于治疗AML
2025-10-19 11:44:20
Check Details
FDA批准首个急性髓性白血病(AML)靶向新药米哚妥林!
2025-10-19 11:44:20
Check Details
普纳替尼进医保了吗?普纳替尼疗效怎么样?
2025-10-19 11:44:20
Check Details
1
2
...
644
645
646
647
648
649
650
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
2
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
3
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
4
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
5
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
6
A Key Therapeutic Breakthrough Against T315I-Mutant CML
7
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
8
Tafasitamab and Lenalidomide Combination Therapy Guide
9
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
10
Gilteritinib Professional Medication Guide & Dosage Management
11
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
12
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia